Rare diseases
Investigational molecules
Locations
Back to Belgium1 898 clinical trials in Mechelen, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Treprostinil Palmitil Inhalation Powder for Patients with Pulmonary Arterial Hypertension
BelgiumStudy on Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Systemic AL Amyloidosis
BelgiumStudy on the Effectiveness and Safety of Osimertinib for Patients with Stage IB-IIIA Non-Small Cell Lung Cancer After Tumor Removal
BelgiumStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
BelgiumStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency
BelgiumStudy on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis
BelgiumStudy of Eftilagimod Alpha and Paclitaxel in Patients with HER2-Negative/Low Metastatic Breast Cancer
BelgiumStudy of datopotamab deruxtecan combined with immunotherapy and carboplatin in patients with advanced or metastatic non-small cell lung cancer
BelgiumStudy comparing 177Lu-edotreotide versus everolimus in patients with inoperable progressive neuroendocrine tumors of gastroenteric or pancreatic origin
BelgiumStudy on Livmoniplimab and Budigalimab with Chemotherapy for Adults with Untreated Metastatic Non-Small Cell Lung Cancer
BelgiumStudy on the Long-Term Safety of Bepranemab for Adults with Progressive Supranuclear Palsy
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Current studies focus on respiratory infections and preventive measures, including innovative vaccine trials for RSV and influenza in various age groups. Research encompasses both standalone treatments and combination therapies.
Special attention is given to protecting vulnerable populations, particularly adults over 60 years of age.
Groundbreaking research in lung cancer treatment, particularly focusing on non-small cell and small cell variants. Studies evaluate novel therapeutic approaches including immunotherapy combinations.
Investigations include both first-line treatments and advanced therapy options.
Studies addressing cardiovascular disease and related conditions, including trials for hypertriglyceridemia and stroke prevention in atrial fibrillation patients.
Focus on both preventive measures and treatment of existing conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
